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Corrected Erratum (supersedes the previous version,
published in the January 2000 issue)
In the October 1998 issue, there were two table errors
in the article “Prenatal Screening for Cystic Fibrosis Car-
riers: An Economic Evaluation,” by Rowley et al. (63:
1160–1174). In the last row of table 5, the difference
in the marginal cost per QALY should be “$8,290.”
Also, table 9, which compares the marginal cost per
QALY for selected preventive measures, may be mis-
leading, since the authors of the cited references used
two different methods of calculation. The values for an-
tepartum Rh immunization, T4 thyroid screening, phe-
nylketonuria screening, and school tuberculin screening
were derived simply by dividing the program costs by
the number of QALYs that the program produced. In
contrast, the other analyses, including our evaluation of
prenatal cystic fibrosis–carrier screening and the evalu-
ations of pneumococcal vaccine and of postmenopausal
estrogen replacement, considered also the costs incurred
by the number of those not screened. This latter meth-
odology is the preferred method, since it makes a com-
parison, often with existing practice; however, since it
often entails high costs for the unscreened group, it may
yield a cost-effectiveness ratio that is more favorable to
screening. The Journal regrets these errors.
